• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: Nutritional approaches in chronic liver diseases.社论：慢性肝病的营养治疗方法
Front Nutr. 2024 Sep 13;11:1480541. doi: 10.3389/fnut.2024.1480541. eCollection 2024.
2
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration.代谢相关脂肪性肝病：术语演变、诊断前沿和治疗视野的探索——述评。
World J Gastroenterol. 2024 May 14;30(18):2387-2390. doi: 10.3748/wjg.v30.i18.2387.
3
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study.代谢功能障碍相关脂肪性肝病及酒精摄入增加的代谢功能障碍相关脂肪性肝病会增加肝细胞癌和新发或失代偿期肝硬化的发生风险：一项韩国全国性研究
Liver Cancer. 2023 Dec 22;13(4):426-437. doi: 10.1159/000535943. eCollection 2024 Aug.
4
Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic.日本代谢相关脂肪性肝病：2019 年冠状病毒病大流行前 10 年的流行趋势及临床背景。
Medicina (Kaunas). 2024 Aug 16;60(8):1330. doi: 10.3390/medicina60081330.
5
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review.代谢功能障碍相关脂肪性肝病（MASLD）：最新综述
J Obes Metab Syndr. 2023 Sep 30;32(3):197-213. doi: 10.7570/jomes23052. Epub 2023 Sep 13.
6
Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.植物源疗法治疗代谢功能障碍相关脂肪性肝病。
Int J Mol Sci. 2024 May 21;25(11):5571. doi: 10.3390/ijms25115571.
7
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.代谢功能障碍相关脂肪性肝病相关肝细胞癌的表型
Clin Gastroenterol Hepatol. 2024 Sep;22(9):1774-1789.e8. doi: 10.1016/j.cgh.2024.03.028. Epub 2024 Apr 10.
8
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。
Obes Facts. 2024;17(4):374-444. doi: 10.1159/000539371. Epub 2024 Jun 7.
9
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus.从代谢功能障碍相关脂肪性肝病到代谢功能障碍相关脂肪性肝病：争议与共识
World J Hepatol. 2023 Dec 27;15(12):1253-1257. doi: 10.4254/wjh.v15.i12.1253.
10
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis.代谢功能障碍相关脂肪性肝病（MASLD）与肝硬化住院患者充血性心力衰竭风险增加的关联：一项倾向评分匹配分析
Cureus. 2024 Jun 15;16(6):e62441. doi: 10.7759/cureus.62441. eCollection 2024 Jun.

本文引用的文献

1
Global burden of liver disease: 2023 update.全球肝病负担：2023 年更新。
J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27.
2
Malnutrition in Patients with Liver Cirrhosis.肝硬化患者的营养不良。
Nutrients. 2021 Feb 7;13(2):540. doi: 10.3390/nu13020540.
3
ESPEN guideline on clinical nutrition in liver disease.ESPEN 临床肝病营养指南。
Clin Nutr. 2019 Apr;38(2):485-521. doi: 10.1016/j.clnu.2018.12.022. Epub 2019 Jan 16.
4
EASL Clinical Practice Guidelines on nutrition in chronic liver disease.EASL 临床实践指南：慢性肝病中的营养问题。
J Hepatol. 2019 Jan;70(1):172-193. doi: 10.1016/j.jhep.2018.06.024. Epub 2018 Aug 23.
5
Current status in the therapy of liver diseases.肝脏疾病治疗的现状。
Int J Mol Sci. 2014 Apr 30;15(5):7500-12. doi: 10.3390/ijms15057500.
6
Nutritional assessment in patients with cirrhosis.肝硬化患者的营养评估
Arq Gastroenterol. 2012 Jan-Mar;49(1):19-27. doi: 10.1590/s0004-28032012000100005.

Editorial: Nutritional approaches in chronic liver diseases.

作者信息

Rodríguez Villafuerte Santiago

机构信息

Department of Hepatology, Hospital Vozandes, Quito, Ecuador.

Directorate of Postgraduate Studies in Health Sciences, Universidad de las Américas, Quito, Ecuador.

出版信息

Front Nutr. 2024 Sep 13;11:1480541. doi: 10.3389/fnut.2024.1480541. eCollection 2024.

DOI:10.3389/fnut.2024.1480541
PMID:39346652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11427349/
Abstract
摘要